Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,581.00
(
1.15%
)
US TECH 100
23,562.40
(
0.18%
)
Dow Jones
46,208.47
(
1.38%
)
Brent Oil
97.61
(
0.84%
)
Bitcoin
71,203.00
(
0.43%
)
News Focus
News Focus
Post# of 257273
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

dav1234

Send PM Follow Ignore
Followers 97
Posts 92809
Boards Moderated 4
Alias Born 10/29/2007

dav1234

Re: None

Monday, 06/10/2013 4:03:38 PM

Monday, June 10, 2013 4:03:38 PM

Post# of 257273
AstraZeneca (AZN -0.1%) has agreed to buy Pearl Therapeutics, a closely held U.S. drugmaker specializing in respiratory-disease treatments, for close to $1.15B. $560M will be paid initially up front, with payments related to development of Pearl Therapeutics' products potentially adding as much as $450M and sales-related payments as much as $140M to the price tag.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today